Hyaluronic acid-coated capecitabine nanostructures for CD44 receptor-mediated targeting in breast cancer therapy
RSC Advances · 2025 · 15 (16) · 12653-12670
DOI: 10.1039/d5ra01275a ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Sruthi Laakshmi Mugundhan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology Kattankulathur-603203 Chengalpattu Tamil Nadu India mot…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Hyaluronic acid-coated capecitabine nanomicelles enhance drug delivery by improving permeability, targeting CD44 receptors, and inducing dose-dependent apoptosis in breast cancer cells, offering a stable and efficient therapy.
Autor:innen und Institutionen
- Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology Kattankulathur-603203 Chengalpattu Tamil Nadu India mothipharma78@gmail.com.
ORCID-Profile: Sruthi Laakshmi Mugundhan, Mothilal Mohan
Zitieren
APA
Mugundhan, S. L., & Mohan, M. (2025). Hyaluronic acid-coated capecitabine nanostructures for CD44 receptor-mediated targeting in breast cancer therapy. RSC Advances, 15(16), 12653-12670. https://doi.org/10.1039/d5ra01275a
Vancouver
Mugundhan SL, Mohan M. Hyaluronic acid-coated capecitabine nanostructures for CD44 receptor-mediated targeting in breast cancer therapy. RSC Advances. 2025;15(16):12653-12670. doi:10.1039/d5ra01275a
BibTeX
@article{Mugundhan2025,
author = {Mugundhan, Sruthi Laakshmi and Mohan, Mothilal},
title = {Hyaluronic acid-coated capecitabine nanostructures for CD44 receptor-mediated targeting in breast cancer therapy},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {16},
pages = {12653--12670},
doi = {10.1039/d5ra01275a}
}
EUVIMED